Calming the Immune System Protects the Brain After Repeated Blows
Source PublicationSignal Transduction and Targeted Therapy
Primary AuthorsMallah, Krieg, Hatchell et al.

Repeated mild head injuries are a mounting concern in public health, particularly within the realm of contact sports. While the initial impacts are physical, new research suggests the brain’s subsequent immune response plays a major role in driving long-term damage. A study utilising a mouse model has identified the ‘complement system’—an ancient part of the immune defence mechanism designed to clear damaged cells—as a significant contributor to post-injury cognitive decline.
Researchers established a model of repetitive head impact to observe the neuroimmune aftermath. Advanced analysis, including mass cytometry and proteomics, revealed that these injuries triggered intense activity in microglia, the brain’s resident immune cells. This activation led to an upregulation of complement proteins and pathways associated with neurodegeneration and neuronal apoptosis (programmed cell death).
The most compelling finding, however, lies in the potential for treatment. The team utilised a site-targeted inhibitor known as CR2-Crry to block the complement system’s activity. When administered up to 21 days after the injury cycle had finished, this treatment successfully modulated the harmful immune response. Consequently, the mice were protected against the cognitive impairment observed in untreated subjects. These data highlight a critical therapeutic window: dampening this specific immune reaction after the trauma stops could prevent the pathological sequelae often seen in repeated head injuries.